Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal Bevacizumab (Avastin) vs Bevacizumab + Diclofenac for Diabetic Macular Edema
IRCT201512144786N3Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2014
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of bevacizumab and diclofenac in diabetic macular edema (DME) and diabetic retinopathy (DR) (2 arms), sponsored by Isfahan University of Medical Sciences. Started Nov 2014; status: completed.
02
Drugs
bevacizumabdiclofenac
03
Conditions
diabetic macular edema (DME)diabetic retinopathy (DR)
Beyond the preview
Go deeper on IRCT201512144786N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201512144786N3.